ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $1,141,000 | +16.0% | 781,492 | +12.7% | 0.00% | 0.0% |
Q4 2016 | $984,000 | -26.7% | 693,191 | -9.6% | 0.00% | 0.0% |
Q3 2016 | $1,342,000 | -0.1% | 766,688 | -2.4% | 0.00% | 0.0% |
Q2 2016 | $1,343,000 | -19.5% | 785,139 | -7.4% | 0.00% | 0.0% |
Q1 2016 | $1,669,000 | +0.8% | 847,433 | -2.8% | 0.00% | 0.0% |
Q4 2015 | $1,656,000 | -3.4% | 871,676 | -2.9% | 0.00% | 0.0% |
Q3 2015 | $1,715,000 | -67.3% | 897,855 | -20.6% | 0.00% | -75.0% |
Q2 2015 | $5,248,000 | -9.0% | 1,131,141 | -14.3% | 0.00% | 0.0% |
Q1 2015 | $5,770,000 | +42.4% | 1,320,354 | +13.1% | 0.00% | +33.3% |
Q4 2014 | $4,051,000 | -20.9% | 1,167,331 | -4.5% | 0.00% | -25.0% |
Q3 2014 | $5,124,000 | -21.4% | 1,222,814 | +9.9% | 0.00% | -20.0% |
Q2 2014 | $6,519,000 | +3.1% | 1,112,476 | +10.8% | 0.01% | 0.0% |
Q1 2014 | $6,323,000 | +7.2% | 1,003,648 | -0.5% | 0.01% | +25.0% |
Q4 2013 | $5,901,000 | – | 1,008,708 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
GAM Holding AG | 523,164 | $997,000 | 0.02% |
STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |